Twice Yearly Injection 96% Reduces HIV Infection Risk by 96%
|
A recent phase 3 trial found that twice-yearly injections
of Lenacapavir reduce the risk of contracting HIV by 96%. |
Why scientists want people living with HIV to start using climate-friendly ARVS
... antiretroviral (ARV) largely used in Kenya that they say is not climate-friendly due to high greenhouse gas (GHG) emissions. Speaking to Healthy ... View article...